HHS Secretary Alex Azar said President Donald Trump is not backing down from an advance notice of proposed rulemaking that would pilot international price referencing for Medicare Part B drugs. In his appearance at the Brookings Institution Friday (Oct. 26), Azar said that the administration is, however, open to suggestions on how to implement the demo. “This President is not turning back: We will put American patients first by reforming how Part B pays for drugs, and this reference pricing...